Evaluating the Structural Robustness of Large-Scale Emerging Industry with Blurring Boundaries

por Li, Yang, Li, Huajiao, Guo, Sui, Liu, Yanxin
Publicado 2022

Observation of Complete Pressure-Jump Protein Refolding in Molecular Dynamics Simulation and Experiment

por Liu, Yanxin, Prigozhin, Maxim B., Schulten, Klaus, Gruebele, Martin
Publicado 2014

Exosomes: A Novel Therapeutic Agent for Cartilage and Bone Tissue Regeneration

por Liu, Yanxin, Ma, Yifan, Zhang, Jingjing, Yuan, Yuan, Wang, Jinqiao
Publicado 2019

A Real-World Disproportionality Analysis of Olaparib: Data Mining of the Public Version of FDA Adverse Event Reporting System

por Shu, Yamin, He, Xucheng, Liu, Yanxin, Wu, Pan, Zhang, Qilin
Publicado 2022

Cost-effectiveness analysis of olaparib as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation in china

por Shu, Yamin, Liu, Yanxin, He, Xucheng, Ding, Yufeng, Zhang, Qilin
Publicado 2022

HIV Infection Enhances TRAIL-Induced Cell Death in Macrophage by Down-Regulating Decoy Receptor Expression and Generation of Reactive Oxygen Species

por Zhu, Dan-Ming, Shi, Juan, Liu, Shilian, Liu, Yanxin, Zheng, Dexian
Publicado 2011

Severe hematuria in a patient receiving bevacizumab and pembrolizumab for metastatic cervical cancer: a case report

por Liu, Yanxin, Dong, Changjiang, He, Xucheng, Wu, Pan, Shu, Yamin, Chen, Li
Publicado 2023

Dual-generation dendritic mesoporous silica nanoparticles for co-delivery and kinetically sequential drug release

por Liu, Yanxin, Huang, Baolin, Zhu, Jiaoyang, Feng, Kailin, Yuan, Yuan, Liu, Changsheng
Publicado 2018

Post-Marketing Safety Concerns With Secukinumab: A Disproportionality Analysis of the FDA Adverse Event Reporting System

por Shu, Yamin, Ding, Yufeng, Liu, Yanxin, Wu, Pan, He, Xucheng, Zhang, Qilin
Publicado 2022

Fluoroquinolone-associated suspected tendonitis and tendon rupture: A pharmacovigilance analysis from 2016 to 2021 based on the FAERS database

por Shu, Yamin, Zhang, Qilin, He, Xucheng, Liu, Yanxin, Wu, Pan, Chen, Li
Publicado 2022

Cost-effectiveness of osimertinib versus standard EGFR-TKI as first-line treatment for EGFR-mutated advanced non-small-cell lung cancer in China

por Shu, Yamin, Ding, Yufeng, He, Xucheng, Liu, Yanxin, Wu, Pan, Zhang, Qilin
Publicado 2022

Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system

por Shu, Yamin, He, Xucheng, Wu, Pan, Liu, Yanxin, Ding, Yufeng, Zhang, Qilin
Publicado 2022

Hematological toxicities in PARP inhibitors: A real‐world study using FDA adverse event reporting system (FAERS) database

por Shu, Yamin, Ding, Yufeng, He, Xucheng, Liu, Yanxin, Wu, Pan, Zhang, Qilin
Publicado 2022

Utilizing network pharmacology and experimental validation to explore the potential molecular mechanisms of raw Pinellia ternate in treating esophageal cancer

por Liu, Yanxin, Bai, Yunfei, Zhang, Jinbang, Silva-Filho, Reginaldo, Zhu, Qingchun, Lei, Zhen
Publicado 2023

Nomogram prediction model called “ADPLCP” for predicting linezolid-associated thrombocytopenia in elderly individuals

por Liu, Yanxin, Wang, Jiang, Liu, Tingting, Xiao, Kun, Yan, Peng, Fang, Xiangqun, Xie, Lixin
Publicado 2023

Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma

por Jiang, Minghong, Liu, Zheng, Xiang, Yang, Ma, Hong, Liu, Shilian, Liu, Yanxin, Zheng, Dexian
Publicado 2011

Symmetry broken and rebroken during the ATP hydrolysis cycle of the mitochondrial Hsp90 TRAP1

por Elnatan, Daniel, Betegon, Miguel, Liu, Yanxin, Ramelot, Theresa, Kennedy, Michael A, Agard, David A
Publicado 2017

Combination of AAV-TRAIL with miR-221-Zip Therapeutic Strategy Overcomes the Resistance to TRAIL Induced Apoptosis in Liver Cancer

por Ma, Sisi, Sun, Jiazeng, Guo, Yabin, Zhang, Peng, Liu, Yanxin, Zheng, Dexian, Shi, Juan
Publicado 2017

Properties of PEDOT nanowire/Te nanowire nanocomposites and fabrication of a flexible thermoelectric generator

por Liu, Haihui, Liu, Pengfei, Zhang, Mengqi, Tian, Zihan, Wang, Ning, Liu, Yanxin, Zhang, Xingxiang
Publicado 2020

N6-methyladenosine reader YTH N6-methyladenosine RNA binding protein 3 or insulin like growth factor 2 mRNA binding protein 2 knockdown protects human bronchial epithelial cells fr...

por Xiao, Kun, Liu, Pengfei, Yan, Peng, Liu, Yanxin, Song, Licheng, Liu, Yuhong, Xie, Lixin
Publicado 2022